Hydroxychloroquine and Cardiovascular Events in Patients with Rheumatoid Arthritis

INTRODUCTION: Cardiovascular disease (CVD) is the leading cause of mortality in patients with rheumatoid arthritis (RA). Some studies have reported a decrease in CVD in patients with RA using hydroxychloroquine (HCQ). Most of these have had fewer participants and have analyzed only composite outcome...

Descripción completa

Detalles Bibliográficos
Autores principales: Cordova Sanchez, Andres, Khokhar, Farzam, Olonoff, Danielle A., Carhart, Robert L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532807/
https://www.ncbi.nlm.nih.gov/pubmed/36197529
http://dx.doi.org/10.1007/s10557-022-07387-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532807/
https://www.ncbi.nlm.nih.gov/pubmed/36197529
http://dx.doi.org/10.1007/s10557-022-07387-z

Ejemplares similares